Vaxart, Inc. - Common Stock
Long
Zaktualizowano

At Long Term Support. Revenue Beat. 682% Upside.

We are right at the support line spanning across 5 years. With revenue beat and 682% upside (average price target), it looks like a safe buy. I hold stocks and April 2025 calls.
Zlecenie aktywne
Fib level .382 roughly coincides with the analyst's average price target.
Uwaga
Still above the trend line.
Uwaga
Above 50 SMA yet again on the weekly. Not it should stay there and challenge 200 SMA.

snapshot
Uwaga
Note: It has made multiple attempts in the past to challenge the 50 SMA but has failed. However, the base held (yellow line).

Wyłączenie odpowiedzialności